Khalayleh 2005.
Study characteristics | ||
Methods | RCT | |
Participants | Incluson criteria:
Excluson criteria: |
|
Interventions | Intervention 1: opioid ‐ excluded from the review
Intervention 2: dopamine antagonist (Comparison 2)
Comparator: placebo
|
|
Outcomes | intraoperative and PONV, rescue droperidol | |
Notes | Setting: Iran Dates: Jan 2002‐Dec 2003 Funding source: not reported Declaration of Interest: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random number table |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | As above |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: "intraoperative and post operative emetic episodes were recorded by doctor who had no knowledge of which study drug the patient had received" |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 3 patients lost out of 150 |
Selective reporting (reporting bias) | Unclear risk | They report no side effects in results (but do not specify which side effects), also do not mention side effects in the methods |
Other bias | Unclear risk | The fact the timing of the interventions are not clear in the Methods raises the risk of other biases |